AP
BSX icon

Atwood & Palmer’s Boston Scientific BSX Stock Holding History

Atwood & Palmer’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$830 Hold
19
– – ﹤0.01% 466
2026
Q2 		$811 Hold
19
– – ﹤0.01% 462
2026
Q1 		$1.19K Hold
19
– – ﹤0.01% 464
2025
Q4 		$1.81K Hold
19
– – ﹤0.01% 449
2025
Q3 		$1.85K Hold
19
– – ﹤0.01% 448
2025
Q2 		$2.04K Hold
19
– – ﹤0.01% 467
2025
Q1 		$1.92K Sell
19
-184
-91% -$18.5K ﹤0.01% 396
2024
Q4 		$18.1K Sell
203
-6
-3% -$528 ﹤0.01% 297
2024
Q3 		$17.5K Buy
209
+190
+1,000% +$15K ﹤0.01% 300
2024
Q2 		$1.46K Sell
19
-65
-77% -$4.76K ﹤0.01% 405
2024
Q1 		$5.75K Buy
84
+65
+342% +$4.18K ﹤0.01% 334
2023
Q4 		$1.1K Buy
+19
New +$1.01K ﹤0.01% 378

Other funds holding BSX

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
PA
Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return

Atwood & Palmer's BSX Position: Q3 2026 in Review

Atwood & Palmer held its Boston Scientific (BSX) position steady in Q3 2026 at 19 shares worth $830. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Atwood & Palmer first reported a position in BSX in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.1K in Q4 2024. 49 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Atwood & Palmer held 19 shares of Boston Scientific worth $830 as of Q3 2026.
  • Atwood & Palmer left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up ﹤0.01% of Atwood & Palmer's portfolio in Q3 2026, its #466 holding.
  • Atwood & Palmer first reported a position in Boston Scientific in Q4 2023 and has held it in 12 quarters since.
  • Atwood & Palmer's Boston Scientific position peaked at $18.1K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Atwood & Palmer's 13F filing for Q3 2026, filed 8 Oct 2026.